HALO

Trimble Partners with HALO Trust for Landmine Clearance in Ukraine

Retrieved on: 
Monday, November 6, 2023
Government, Geographic data and information, HALO Trust, Satellite navigation, Person, Weapon, TRMB, Fear, GNSS, Trimble, Rainforest Foundation Fund, Society, Safety, HALO, Satellite navigation device

WESTMINSTER, Colo., Nov. 6, 2023 /PRNewswire/ -- Trimble (NASDAQ: TRMB) and the Trimble Foundation Fund have partnered with The HALO Trust, the world's largest landmine-clearing non-profit organization, to help expand its demining operations across Ukraine. The Foundation Fund directed grant focuses on strengthening the HALO Trust's capacity to locate and remove landmines, unexploded ordnance, and other explosive hazards from civilian areas to create safer communities.

Key Points: 
  • WESTMINSTER, Colo., Nov. 6, 2023 /PRNewswire/ -- Trimble (NASDAQ: TRMB) and the Trimble Foundation Fund have partnered with The HALO Trust, the world's largest landmine-clearing non-profit organization, to help expand its demining operations across Ukraine.
  • A new deployment of 255 high-precision Trimble DA2 GNSS receivers with Trimble Catalyst™ corrections service has been provided to HALO by Trimble's Geospatial and Positioning Services businesses.
  • Only then can families rebuild their lives and walk without fear," said Chris Whatley, executive director of The HALO Trust USA.
  • Supporting the HALO Trust's important and impactful work helps the people of Ukraine and other countries worldwide recover and rebuild after conflict."

Rampart Bioscience Announces $85M Series A Financing to Develop Novel DNA-Based Medicines with Veteran Team

Retrieved on: 
Tuesday, October 24, 2023
Biotechnology, Health, Genetics, Pharmaceutical, Clinical Trials, OrbiMed, Hypophosphatasia, Alexion, HealthCap, General partnership, MBA, Electro-technical officer, Code, HPP, Disease, CSL Behring, Safety, HALO, Patient, DNA, Vaccine, Pharmaceutical industry, Rampart

Rampart Bioscience, Inc., a biotechnology company developing next-generation biologics, today announced an $85 million Series A financing to create medicines that aim to unburden patients from disease and their treatments.

Key Points: 
  • Rampart Bioscience, Inc., a biotechnology company developing next-generation biologics, today announced an $85 million Series A financing to create medicines that aim to unburden patients from disease and their treatments.
  • The new financing builds on an initial $40 million seed investment from OrbiMed.
  • The Rampart team has tremendous heart and a fierce commitment to reshaping the treatment landscape for those in dire need of better options,” said Louis Breton, Rampart Co-founder, Chief Executive Officer, and Board Director.
  • “Rampart’s DNA medicines contain novel structural elements that drive nuclear trafficking and retention while avoiding immune responses,” said Jeffrey Bartlett, Ph.D., Rampart Co-founder and Chief Innovation and Technical Officer.

HALO Precision Diagnostics Collaborating with Bayer to Advance Contrast-Enhanced MRI

Retrieved on: 
Tuesday, October 17, 2023
Biotechnology, Health, Radiology, Clinical Trials, Oncology, Cardiovascular disease, Partnership, Pharmacokinetics, Abdomen, Breast cancer, Pelvis, Central nervous system, Ageing, Safety, Thorax, R, Extremities, Neck, Head, MRI, Prostate cancer, Patient, HALO, Medical device, Medical imaging, Bayer

HALO Precision Diagnostics (“HALO”), a leader in early disease detection using precision diagnostics, today announced a collaboration with Bayer, ​​a global leader in radiology, to join QUANTI, Bayer’s Phase III clinical development program for gadoquatrane.

Key Points: 
  • HALO Precision Diagnostics (“HALO”), a leader in early disease detection using precision diagnostics, today announced a collaboration with Bayer, ​​a global leader in radiology, to join QUANTI, Bayer’s Phase III clinical development program for gadoquatrane.
  • Bayer initiated the QUANTI studies to evaluate the safety and efficacy of gadoquatrane, an investigational gadolinium-based contrast agent, in MRI.
  • Contrast-enhanced MRI plays a key role in the healthcare continuum, providing a radiation-free imaging method to obtain detailed images of the body.
  • “Our partnership with Bayer is the latest example of HALO leading the way when it comes to advancements supporting early disease detection,” said Bernadette Greenwood, chief research officer, HALO.

HALO Precision Diagnostics Appoints Thomas P. Slavin, M.D., as Chief Scientific Officer

Retrieved on: 
Thursday, October 12, 2023
Oncology, Health, Genetics, Health Technology, Other Health, Biotechnology, Cardiovascular disease, Multimedia, Pediatrics, Breast cancer, Slavín, Patient, Education, Cancer, Genetic testing, Prostate cancer, Myriad Genetics, Research, HALO, Management, Pharmaceutical industry, Medical device, Medical imaging

HALO Precision Diagnostics (“HALO”), a leader in early disease detection using precision diagnostics, today announced the appointment of Thomas P. Slavin, M.D., as chief scientific officer.

Key Points: 
  • HALO Precision Diagnostics (“HALO”), a leader in early disease detection using precision diagnostics, today announced the appointment of Thomas P. Slavin, M.D., as chief scientific officer.
  • View the full release here: https://www.businesswire.com/news/home/20231012826670/en/
    Thomas P. Slavin, M.D., HALO chief scientific officer: “I have dedicated my career to bringing genetic solutions to patients through education, research, and advocacy.
  • Slavin is a highly respected clinical leader and scientist in genetic testing,” said Michael Uhl, HALO chief executive officer.
  • Last month, HALO announced the appointment of John Craighead, Ph.D., as chief operating officer and chief financial officer.

Somewear Labs Supports Alpha 5 Project with Critical Communications Platform During Record-Setting Formation Skydive

Retrieved on: 
Thursday, September 28, 2023
Communication, Altitude, Special Operations Warrior Foundation, Guinness, PJS, Guinness World Records, Organization, SOWF, Risk, SAN, HALO, Entrepreneurship, Health, New Mexico Military Institute, Environment, Safety

SAN FRANCISCO, Sept. 28, 2023 /PRNewswire-PRWeb/ -- Today, Somewear Labs, the technology company enabling critical communications for defense, public safety, and commercial teams, announced its participation in the Alpha 5 Project, a mission to set a new world record for the highest HALO (high altitude, low opening) formation skydive and raise $1 million for the Special Operations Warrior Foundation (SOWF). Somewear Labs partnered with Operator Solutions, a leading provider of specialized search and rescue solutions and the team behind the Alpha 5 Project, to provide critical and reliable communication solutions to ensure the health and safety of the jumpers during this remarkable mission. The record-setting jump took place on Thursday, September 28, 2023 at The New Mexico Military Institute in Roswell, NM. The five participating jumpers included four current and former U.S. Air Force Special Warfare Pararescue Specialists (PJs) and entrepreneur, adventurist, and philanthropist Larry Connor.

Key Points: 
  • Accompanied by a balloon pilot and O2 Tech, the jumpers followed HALO safety protocols, wearing full oxygen equipment and human-performance sensors powered by Somewear.
  • From there, the jumpers exited the balloon and linked arms in a five-person formation before safely separating and landing.
  • "We are honored to have participated in this extraordinary, world record-setting event," said James Kubik, Co-Founder and CEO at Somewear Labs.
  • Somewear's software-based critical communications platform provided an elevated level of safety, accountability, and awareness for the Alpha 5 Project team.

Alpha 5 Project Sets New HALO Formation Skydiving World Record to Support Children of Fallen Warriors

Retrieved on: 
Thursday, September 28, 2023
Professional Services, Family, Philanthropy, Consumer, Residential Building & Real Estate, Defense, Construction & Property, Foundation, Children, Finance, Veterans, Military, Astronaut, Captain, Altitude, Alpha, Axiom Space, Therapy, Special Operations Warrior Foundation, Special forces, Guinness, Special operations, Balloon Pilot Badge, PJS, Guinness World Records, SOWF, HALO, RET, Project, NMMI, Management

From there, the jumpers exited the balloon, and linked arms in a five-person formation before separating and landing roughly 14 miles east/southeast from the launch site.

Key Points: 
  • From there, the jumpers exited the balloon, and linked arms in a five-person formation before separating and landing roughly 14 miles east/southeast from the launch site.
  • An official observer from Guinness World Records was onsite to validate the jump.
  • “I could not be prouder of the exemplary team behind the Alpha 5 Project that set this world record – including the PJs, and technical experts who enabled us to do this safely and successfully,” said Connor.
  • “We share this record with each and every person who contributed to the mission.

New Solera HALO™ Omni-Condition Management Platform Transforms Benefit Management with Integration of Solera-Curated and Existing Customer-Contracted Point Solutions

Retrieved on: 
Tuesday, September 26, 2023
CFOS, HALO, MSK, Mental health, Fatigue, Sales, Online shopping, Risk management, Solera

The HALO platform enables eligible consumers to access all relevant benefits programs and health offerings via a unified, flexible user interface, expertly guiding them to their personal, best-fit solutions.

Key Points: 
  • The HALO platform enables eligible consumers to access all relevant benefits programs and health offerings via a unified, flexible user interface, expertly guiding them to their personal, best-fit solutions.
  • The platform’s single contract and integration eliminates the chaos and expense of managing point solutions individually, and HALO’s unified reporting dashboard quickly and easily assesses the effectiveness of all programs, side-by-side.
  • But the answer isn’t to throw the baby out with the bathwater,” said Mary Langowski, CEO at Solera Health.
  • Simplified benefits management: With its integrated network of benefits programs, HALO addresses point solution fatigue and lack of accountability, eliminating the need to manage a myriad of disparate point solutions.

IPVideo to Launch New HALO Cloud App & 10-Year Product Warranty for HALO 3C Cloud Customers With a 10-Year Cloud License at GSX 2023

Retrieved on: 
Wednesday, September 6, 2023
Cloud, BAY, Radiation, Emergency, Noise, Android, Privacy, ERS, Organization, School, Gilley, HALO, GSX, Sentry, Apple, Weapon, Software, Video game, Mobile phone

BAY SHORE, N.Y., Sept. 6, 2023 /PRNewswire-PRWeb/ -- IPVideo Corporation, a leading provider of physical security solutions, today announced the company will introduce its all-new HALO Cloud Application in booth #3245 at GSX 2023 in Dallas, TX, September 11th-13th. In addition, the company announces a new 10-Year product warranty for HALO 3C Cloud customers that purchase a 10-year cloud license, effective on September 1, 2023. The new HALO Cloud App was designed to provide customers with a modern tool that places crucial alerts at their fingertips, wherever they might be in a building. The new warranty aims to better protect their technology and investment.

Key Points: 
  • In addition, the company announces a new 10-Year product warranty for HALO 3C Cloud customers that purchase a 10-year cloud license, effective on September 1, 2023.
  • The new HALO Cloud App was designed to provide customers with a modern tool that places crucial alerts at their fingertips, wherever they might be in a building.
  • With an updated HALO Cloud web interface, systems administrators can easily create and manage multiple notifications triggered by selected events for specific groups of devices.
  • "We are excited to share our new HALO Cloud App with GSX attendees and are pleased to announce our new 10-year warranty for HALO 3C Cloud users who purchase a 10-year cloud license and provide organizations with an even greater return on investment."

HALO: Which Hydrogen Stocks Could Benefit from $1.25bn Project?

Retrieved on: 
Tuesday, August 22, 2023
Hydrogen, News, Communication, Advertising, Use, Interview, Disclaimer, Electrolysis, Marketing, Bank statement, Overalls, Fertilizer, Agriculture, Risk, CAD, CF Industries, Research, Broker-dealer, Hydrogen technologies, BUY, Government, Investment, Ammonia, Rystad Energy, HALO, OTC, SEDAR, CO2, Air Products, Growth, Heat, Transport, Publishing, CF, NYSE, NextEra Energy, Lithium, Oil, Coal, Renewable energy, Cryptocurrency, Chemical substance

HALO: Which Hydrogen Stocks Could Benefit from $1.25bn Project?

Key Points: 
  • HALO: Which Hydrogen Stocks Could Benefit from $1.25bn Project?
  • This extensive reinvestment in the hydrogen industry is what has resulted in the company backing the HALO project.
  • It's this boiler technology which Jericho is hoping can play a major part in turning the tri-state area into a hydrogen powerhouse through the HALO Hydrogen Hub project.
  • Many industry players look poised to benefit from, and contribute to, the HALO hydrogen hub if the project wins its funding.

HALO Precision Diagnostics Appoints John Craighead as Chief Operating Officer and Chief Financial Officer

Retrieved on: 
Wednesday, August 16, 2023
Technology, Other Technology, Health Technology, Software, Other Health, Biotechnology, Hardware, General Health, Health, Oncology, Molecular biology, Cell biology, Lehman Brothers, St. Olaf College, Cardiovascular disease, Human Genome Sciences, Multimedia, Medicine, Chemistry, GRAIL, Scripps Research, Patient, HALO, Corporation, Breast cancer, Prostate cancer, Corporate development, Management, Medical imaging, Strategy

HALO Precision Diagnostics (“HALO”), the leader in early disease detection using precision diagnostics, today announced the appointment of John Craighead, Ph.D., as chief operating officer and chief financial officer.

Key Points: 
  • HALO Precision Diagnostics (“HALO”), the leader in early disease detection using precision diagnostics, today announced the appointment of John Craighead, Ph.D., as chief operating officer and chief financial officer.
  • View the full release here: https://www.businesswire.com/news/home/20230816108264/en/
    “John’s deep life science industry experience and business and financial acumen will serve HALO well as we pursue our life-saving mission,” said Michael Uhl, HALO chief executive officer.
  • The company has clinically validated care pathways for prostate cancer, breast cancer, and cardiovascular disease, as well as plans for neurodegenerative and other life-threatening diseases.
  • “HALO has assembled an impressive team spanning business, healthcare, and technology, and I am excited to join in the mission to save lives and expand access to precision diagnostics,” said Craighead.